A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies

NCT05032040 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Clear Cell Carcinoma
Endometrial Cancer
Cervical Carcinoma
Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Interventions

BIOLOGICAL: vudalimab

Sponsor

Xencor, Inc.

Collaborators

[object Object]